http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0213481-A3

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06078
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-065
filingDate 1986-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1989-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0213481-A3
titleOfInvention N-terminally substituted dipeptide amides no. 2
abstract This invention encompasses compounds of the formula n nand the pharmaceutically acceptable acid addition salts thereof nwherein R¹ is lower alkoxy or -O-(CH₂) n -phenyl where the nphenyl may be optionally substituted with halogen, -NO₂, -CN, n-NH₂ or lower alkyl wherein n is 1 to 4; R² and R³ nrepresent lower alkyl, halogen, lower alkoxy or one of R² or nR³ is hydrogen and the other is lower alkyl, lower alkoxy, or nhalogen; R⁴, R⁵, R⁷, R⁸, and R⁹ represent hydrogen or nlower alkyl, R⁶ represents hydrogen, lower alkyl, lower nalkenyl, or -(CH₂) m -cycloalkyl wherein m is 1 to 4 and the ncycloalkyl has 3 to 8 carbon atoms; R¹⁰ is -(CH₂) p -phenyl nwherein p is 1 to 4; and v represents an asymmetric carbon that nmay be racemic or have the D or L Configuration; nw represents an asymmetric carbon when R⁷ and R⁸ are not nthe same that may be racemic or have the D or L configuration. nThis invention also encompasses compounds where R¹ is nhydroxy, provided at least one of R⁴, R⁵, R⁶ or R⁹ is nlower alkyl. The compounds of this invention are useful nanalgesic agents.
priorityDate 1985-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0154234-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4454120-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4380535-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811

Total number of triples: 22.